Beneficient
Financial highlights
| Metric | FY 03/31/25 | FY 03/31/24 | FY 03/31/23 | FY 03/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | -$7.9M | -$98.7M | -$104.9M | — | $55.3M |
| Operating expenses | $16.2M | $2.5B | $148.3M | — | $126.4M |
| Operating income | -$24.2M | -$2.6B | -$253.2M | — | -$71.1M |
| Interest expense | — | $17.6M | $15.5M | — | $27.5M |
| Pretax income | -$723,000 | -$2.7B | -$253.2M | — | -$105.1M |
| Income tax expense | $80,000 | $788,000 | -$1.1M | — | $0 |
| Net income | -$803,000 | -$2.1B | -$131.0M | — | -$63.0M |
| Balance Sheet | |||||
| Cash and equivalents | $1.3M | $7.9M | $8.7M | $70.6M | — |
| Total assets | $354.9M | $368.5M | $2.9B | $3.1B | — |
| Total liabilities | $299.3M | $309.6M | $231.8M | $241.4M | — |
| Stockholders' equity | -$34.9M | -$192.1M | $1.7B | $1.9B | $1.1B |
| Cash Flow Statement | |||||
| Cash from operations | -$37.7M | -$58.2M | -$95.1M | — | -$57.0M |
| Depreciation and amortization | $1.7M | $3.8M | $3.6M | — | $2.0M |
| Stock-based compensation | $5.6M | $39.1M | $10.1M | — | $23.2M |
| Capital expenditure | $1.1M | $1.8M | $2.1M | — | $4.2M |
| Free cash flow | -$38.8M | -$60.0M | -$97.2M | — | -$61.2M |
| Impairments | $3.7M | $2.4B | $0 | — | — |
Shares outstanding 14.2M
Annual filing data through FY ended March 31, 2025; float as of July 15, 2026.